Dare Bioscience Inc
DARE
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.75M
Close$
$0.17
79.7% downside
Current Fair Value
79.7% downsideOvervalued by 79.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $11.75 Million |
|---|---|
| Enterprise Value | $148,959.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.2 |
| Beta | 1.01 |
| Outstanding Shares | 14,889,832 |
Return
| Return on Equity | 1961.64% |
|---|---|
| Return on Assets | -49.12% |
| Return on Invested Capital | -212.53% |
Valuation & Multiples
| P/E Ratio | -0.99 |
|---|---|
| PEG | 3.86 |
| Price to Sales | - |
| Price to Book Ratio | -0.85 |
| Enterprise Value to Revenue | 0.11 |
| Enterprise Value to EBIT | -0.01 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 6.83 |
| Debt to Equity | -1.82 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.30
Average shareholder expectationRevenue Estimate
$1,667
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$2.02 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 8.74%▲ 1.69% |
|---|---|
| Total Invested | $2.75M▲ 47.26% |
| Investors Holding | 27▲ 3.00% |
ESG Score
No data